ABclonal: China's healthcare-focused LYFE Capital leads $92m funding in biotech firm ABclonal
Sequoia Capital China was among the investors in the funding round. The post China's healthcare-focused LYFE Capital leads $92m funding in biotech firm ABclonal appeared first on DealStreetAsia.
Read full article »
ABclonal is a China-based biotechnology company that researches and develops antibodies and molecular enzyme products for industries such as life science and pharmaceuticals.
Read more